Cargando…
SARS-CoV-2 and probable lung cancer risk
[Image: see text] The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term co...
Autores principales: | Khiali, Sajad, Rezagholizadeh, Afra, Entezari-Maleki, Taher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124879/ https://www.ncbi.nlm.nih.gov/pubmed/35677665 http://dx.doi.org/10.34172/bi.2022.23266 |
Ejemplares similares
-
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
por: Rezagholizadeh, Afra, et al.
Publicado: (2021) -
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial
por: Khiali, Sajad, et al.
Publicado: (2023) -
Anticoagulation in COVID-19: DDI Perspective
por: Khiali, Sajad, et al.
Publicado: (2020) -
Tocilizumab in COVID-19 management: addressing time of starting treatment
por: Khiali, Sajad, et al.
Publicado: (2023) -
SARS-CoV-2: Receptor and Co-receptor Tropism Probability
por: Eslami, Narges, et al.
Publicado: (2022)